Mind Net Receivables vs Other Stockholder Equity Analysis

MNMD Stock

USD 8.40 0.21 2.56%

Mind Medicine financial indicator trend analysis is infinitely more than just investigating Mind Medicine recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mind Medicine is a good investment. Please check the relationship between Mind Medicine Net Receivables and its Other Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

Net Receivables vs Other Stockholder Equity

Net Receivables vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mind Medicine Net Receivables account and Other Stockholder Equity. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Mind Medicine's Net Receivables and Other Stockholder Equity is -0.52. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Mind Medicine, assuming nothing else is changed. The correlation between historical values of Mind Medicine's Net Receivables and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Mind Medicine are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Net Receivables i.e., Mind Medicine's Net Receivables and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.52

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Net Receivables

Other Stockholder Equity

Most indicators from Mind Medicine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mind Medicine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.As of November 14, 2024, Selling General Administrative is expected to decline to about 23.3 M. In addition to that, Tax Provision is expected to decline to about (1.1 M)

	2022	2023	2024 (projected)
Total Operating Expenses	66.3M	90.7M	62.6M
Cost Of Revenue	3.2M	3.2M	2.5M

Total Operating Expenses Cost Of Revenue

Mind Medicine fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Other Liab	Non Current Liabilities Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Retained Earnings Total Equity	Non Current Liabilities Other
Total Assets		0.74	0.78	0.99	0.97	-0.99	-0.86	0.86	1.0	1.0	-0.44	0.96	0.45	0.53	0.97	0.73	1.0	-0.45	0.93	-0.87	0.39	0.92	0.9	0.72	-0.74	-0.61
Other Current Liab	0.74		1.0	0.65	0.79	-0.67	-0.98	0.75	0.72	0.72	-0.87	0.84	0.87	0.67	0.84	0.99	0.73	-0.91	0.67	-0.92	0.87	0.85	0.6	0.18	-0.89	-0.98
Total Current Liabilities	0.78	1.0		0.7	0.83	-0.72	-0.99	0.8	0.76	0.76	-0.86	0.88	0.86	0.66	0.87	0.99	0.77	-0.89	0.71	-0.93	0.86	0.87	0.64	0.22	-0.87	-0.97
Total Stockholder Equity	0.99	0.65	0.7		0.93	-1.0	-0.79	0.81	0.99	0.99	-0.37	0.9	0.32	0.47	0.92	0.64	0.99	-0.35	0.9	-0.81	0.29	0.86	0.93	0.78	-0.68	-0.51
Net Tangible Assets	0.97	0.79	0.83	0.93		-0.95	-0.9	0.91	0.97	0.97	-0.48	0.99	0.61	0.54	0.99	0.79	0.97	-0.55	0.97	-0.91	0.5	0.94	0.79	0.58	-0.74	-0.69
Net Debt	-0.99	-0.67	-0.72	-1.0	-0.95		0.81	-0.82	-1.0	-1.0	0.37	-0.93	-0.37	-0.45	-0.94	-0.67	-1.0	0.39	-0.94	0.82	-0.32	-0.87	-0.89	-0.74	0.7	0.54
Retained Earnings	-0.86	-0.98	-0.99	-0.79	-0.9	0.81		-0.85	-0.85	-0.85	0.78	-0.94	-0.81	-0.68	-0.93	-0.97	-0.85	0.82	-0.8	0.96	-0.78	-0.93	-0.72	-0.35	0.88	0.93
Accounts Payable	0.86	0.75	0.8	0.81	0.91	-0.82	-0.85		0.85	0.85	-0.55	0.91	0.68	0.57	0.9	0.79	0.85	-0.49	0.86	-0.8	0.6	0.88	0.7	0.44	-0.53	-0.67
Cash	1.0	0.72	0.76	0.99	0.97	-1.0	-0.85	0.85		1.0	-0.43	0.95	0.44	0.48	0.96	0.72	1.0	-0.45	0.95	-0.85	0.38	0.89	0.88	0.7	-0.73	-0.6
Cash And Short Term Investments	1.0	0.72	0.76	0.99	0.97	-1.0	-0.85	0.85	1.0		-0.43	0.95	0.44	0.48	0.96	0.72	1.0	-0.45	0.95	-0.85	0.38	0.89	0.88	0.7	-0.73	-0.6
Net Receivables	-0.44	-0.87	-0.86	-0.37	-0.48	0.37	0.78	-0.55	-0.43	-0.43		-0.55	-0.8	-0.42	-0.52	-0.9	-0.43	0.88	-0.36	0.62	-0.95	-0.52	-0.36	0.15	0.66	0.9
Common Stock Shares Outstanding	0.96	0.84	0.88	0.9	0.99	-0.93	-0.94	0.91	0.95	0.95	-0.55		0.67	0.56	0.99	0.85	0.95	-0.63	0.96	-0.93	0.58	0.95	0.76	0.5	-0.78	-0.76
Inventory	0.45	0.87	0.86	0.32	0.61	-0.37	-0.81	0.68	0.44	0.44	-0.8	0.67		0.55	0.63	0.89	0.44	-0.89	0.51	-0.72	0.94	0.67	0.2	-0.22	-0.61	-0.92
Other Current Assets	0.53	0.67	0.66	0.47	0.54	-0.45	-0.68	0.57	0.48	0.48	-0.42	0.56	0.55		0.64	0.62	0.48	-0.45	0.34	-0.78	0.46	0.79	0.63	0.43	-0.65	-0.62
Other Stockholder Equity	0.97	0.84	0.87	0.92	0.99	-0.94	-0.93	0.9	0.96	0.96	-0.52	0.99	0.63	0.64		0.83	0.96	-0.6	0.93	-0.95	0.54	0.98	0.82	0.59	-0.81	-0.74
Total Liab	0.73	0.99	0.99	0.64	0.79	-0.67	-0.97	0.79	0.72	0.72	-0.9	0.85	0.89	0.62	0.83		0.72	-0.91	0.68	-0.88	0.91	0.83	0.57	0.13	-0.83	-0.98
Total Current Assets	1.0	0.73	0.77	0.99	0.97	-1.0	-0.85	0.85	1.0	1.0	-0.43	0.95	0.44	0.48	0.96	0.72		-0.45	0.94	-0.86	0.38	0.9	0.88	0.7	-0.73	-0.6
Intangible Assets	-0.45	-0.91	-0.89	-0.35	-0.55	0.39	0.82	-0.49	-0.45	-0.45	0.88	-0.63	-0.89	-0.45	-0.6	-0.91	-0.45		-0.46	0.73	-0.92	-0.6	-0.25	0.2	0.8	0.97
Common Stock	0.93	0.67	0.71	0.9	0.97	-0.94	-0.8	0.86	0.95	0.95	-0.36	0.96	0.51	0.34	0.93	0.68	0.94	-0.46		-0.79	0.39	0.84	0.69	0.53	-0.62	-0.57
Other Liab	-0.87	-0.92	-0.93	-0.81	-0.91	0.82	0.96	-0.8	-0.85	-0.85	0.62	-0.93	-0.72	-0.78	-0.95	-0.88	-0.86	0.73	-0.79		-0.63	-0.98	-0.76	-0.48	0.91	0.85
Non Current Liabilities Total	0.39	0.87	0.86	0.29	0.5	-0.32	-0.78	0.6	0.38	0.38	-0.95	0.58	0.94	0.46	0.54	0.91	0.38	-0.92	0.39	-0.63		0.55	0.21	-0.28	-0.6	-0.93
Capital Surpluse	0.92	0.85	0.87	0.86	0.94	-0.87	-0.93	0.88	0.89	0.89	-0.52	0.95	0.67	0.79	0.98	0.83	0.9	-0.6	0.84	-0.98	0.55		0.82	0.58	-0.82	-0.76
Net Invested Capital	0.9	0.6	0.64	0.93	0.79	-0.89	-0.72	0.7	0.88	0.88	-0.36	0.76	0.2	0.63	0.82	0.57	0.88	-0.25	0.69	-0.76	0.21	0.82		0.87	-0.67	-0.45
Net Working Capital	0.72	0.18	0.22	0.78	0.58	-0.74	-0.35	0.44	0.7	0.7	0.15	0.5	-0.22	0.43	0.59	0.13	0.7	0.2	0.53	-0.48	-0.28	0.58	0.87		-0.37	0.0
Retained Earnings Total Equity	-0.74	-0.89	-0.87	-0.68	-0.74	0.7	0.88	-0.53	-0.73	-0.73	0.66	-0.78	-0.61	-0.65	-0.81	-0.83	-0.73	0.8	-0.62	0.91	-0.6	-0.82	-0.67	-0.37		0.85
Non Current Liabilities Other	-0.61	-0.98	-0.97	-0.51	-0.69	0.54	0.93	-0.67	-0.6	-0.6	0.9	-0.76	-0.92	-0.62	-0.74	-0.98	-0.6	0.97	-0.57	0.85	-0.93	-0.76	-0.45	0.0	0.85

Click cells to compare fundamentals

Mind Medicine Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
MSFT	Microsoft

When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:

How To Invest In Mind

Details

Is Mind Stock a good investment?

Details

What is Mind Medicine's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mind Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.

You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.04)

Return On Assets

(0.25)

Return On Equity

(0.55)

The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Mind Net Receivables vs Other Stockholder Equity Analysis

Net Receivables vs Other Stockholder Equity

Net Receivables vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Net Receivables

Other Stockholder Equity

Mind Medicine fundamental ratios Correlations

Mind Medicine Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Stockholder Equity
Retained Earnings	- 0.99	Total Current Liabilities
Net Debt	- 0.99	Total Assets